ReviewJournal of clinical medicine2024

Ustekinumab or Vedolizumab after Failure of Anti-TNF Agents in Crohn's Disease: A Review of Comparative Effectiveness Studies.

Mohmmed Tauseef Sharip et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.